Sergio Carmona
National Health Laboratory Service
92 Papers
194 Citations
Sergio Carmona is an academic researcher from National Health Laboratory Service. The author has contributed to research in topics: Medicine & Viral load. The author has an hindex of 26, co-authored 78 publications. Previous affiliations of Sergio Carmona include University of the Witwatersrand.
Chat about Author
Papers
Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.
Lukas E. Brümmer,Stephan Katzenschlager,Mary Gaeddert,Christian Erdmann,Stephani Schmitz,Marc Bota,Maurizio Grilli,Jan Larmann,Markus A. Weigand,Nira R. Pollock,Aurélien Macé,Sergio Carmona,Stefano Ongarello,Jilian A. Sacks,Claudia M. Denkinger,Claudia M. Denkinger +15 more
TL;DR: A systematic review and meta-analysis of commercially available rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2 up until 30 April 2021 was conducted in this paper.
Adult antiretroviral therapy guidelines 2017
Graeme Meintjes,Michelle Moorhouse,Sergio Carmona,Natasha Davies,Sipho Dlamini,Cloete van Vuuren,Thandekile C. Manzini,Moeketsi Mathe,Yunus Moosa,Jennifer Nash,Jeremy Nel,Yoliswa Pakade,Joana Woods,Gert U. van Zyl,Francesca Conradie,Francois Venter +15 more
TL;DR: These guidelines are intended as an update to those published in the Southern African Journal of HIV Medicine in 2014 and the update on when to initiate antiretroviral therapy in 2015.
Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa’s National HIV Program: Data From a Nationwide Laboratory Cohort
Sergio Carmona,Sergio Carmona,Jacob Bor,Jacob Bor,Cornelius Nattey,Brendan Maughan-Brown,Mhairi Maskew,Matthew P. Fox,Matthew P. Fox,Deborah K. Glencross,Deborah K. Glencross,Nathan Ford,William B. MacLeod,William B. MacLeod +13 more
TL;DR: The proportion of patients presenting with advanced HIV disease in South Africa remains consistently high despite ART scale-up, representing a large and avoidable burden of morbidity.
145
Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
Lucas E Hermans,Lucas E Hermans,Michelle Moorhouse,Sergio Carmona,Sergio Carmona,Diederick E. Grobbee,Diederick E. Grobbee,L. Marije Hofstra,Douglas D. Richman,Hugo A. Tempelman,Willem D F Venter,Annemarie M. J. Wensing +11 more
TL;DR: In this large cohort, low-level viraemia occurred frequently and increased the risk of virological failure and switch to second-line ART, which needs to be incorporated into WHO guidelines to meet UNAIDS-defined targets aimed at halting the global HIV epidemic.
Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries.
Shirley Lee Lecher,Dennis Ellenberger,Andrea A. Kim,Peter N. Fonjungo,Simon Agolory,Marie Yolande Borget,Laura N. Broyles,Sergio Carmona,Geoffrey Chipungu,Kevin M. De Cock,Varough M. Deyde,Marie Downer,Sundeep Gupta,Jonathan E. Kaplan,Charles Kiyaga,Nancy W. Knight,William B. MacLeod,Boniface Makumbi,Hellen Muttai,Christina Mwangi,J. Mwangi,Michael Mwasekaga,Lucy Ng’ang’a,Yogan Pillay,Abdoulaye Dieng Sarr,Souleymane Sawadogo,Daniel E. Singer,Wendy Stevens,Christiane Adje Toure,John N. Nkengasong +29 more
TL;DR: This report highlights the initial successes and challenges of viral load monitoring in seven countries that have chosen to scale up viral load testing as a national monitoring strategy for patients on ART in response to World Health Organization (WHO) recommendations.